Clinical Trial Update: Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) [Phase 4]

View source ↗

Summary

Phase 4 safety trial evaluating aztreonam lysine for inhalation (AZLI) in early bronchiolitis obliterans syndrome; study completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans Syndrome

Drugs mentioned

• Aztreonam lysine for inhalation (aztreonam lysine)

Snippet

Sponsor: Duke University | Conditions: Complication of Transplanted Lung | Phase 4 | Status: COMPLETED | Results posted: 2015-11-26